Erratum to: Abu-Rustum et al. NCCN Guidelines Insights on Uterine Neoplasms, Version 3.2021. J Natl Compr Canc Netw 2021;19(8):888–895.
In the August 2021 issue of JNCCN, the NCCN Guidelines Insights on Uterine Neoplasms, Version 3.2021 (J Natl Compr Canc Netw 2021;19:888–895) was published with an error.
The list of supporters for the Continuing Education Activity, printed on page 888, was incorrect. The correct list of supporters should read: This activity is supported by educational grants from Agios Pharmaceuticals; AstraZeneca; Clovis Oncology, Inc.; Daiichi Sankyo; Eisai; Epizyme Inc.; Novartis; and Pharmacyclics LLC, an AbbVie Company and Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC. This activity is supported by an independent medical education grant from Bristol-Myers Squibb, and Regeneron Pharmaceuticals, Inc. and Sanofi Genzyme. This activity is supported by an independent medical educational grant from Mylan Inc. This activity is supported by a medical education grant from Karyopharm Therapeutics.
A corrected copy of the article is available online at JNCCN.org. The editorial office apologizes for this error.